Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.

@article{Konishi2016ImpactOL,
  title={Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.},
  author={Hirokazu Konishi and Katsumi Miyauchi and Jun Shitara and Hirohisa Endo and Hideki Wada and Shinichiro Doi and Ryo Naito and Shuta Tsuboi and Manabu Ogita and Tomotaka Dohi and Takatoshi Kasai and Shinya Okazaki and Kikuo Isoda and Satoru Suwa and Hiroyuki Daida},
  journal={The American journal of cardiology},
  year={2016},
  volume={118 12},
  pages={1781-1785}
}
Patients with diabetes mellitus (DM) are at twofold to fourfold higher cardiovascular risk than those without DM. Serum levels of lipoprotein(a) (Lp(a)) can be risk factors for adverse events. However, the clinical implications of Lp(a) in patients with DM who underwent percutaneous coronary intervention (PCI) is unknown. The aim of the study was to… CONTINUE READING